InnovAge Holding Corp. (INNV) Revenue History
InnovAge Holding Corp. (INNV) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-06-30 | $637.80M |
| 2022-06-30 | $698.64M |
| 2023-06-30 | $688.09M |
| 2024-06-30 | $763.86M |
| 2025-06-30 | $853.70M |
How INNV compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | $874.84M |
| NEOG | Neogen Corporation | $870.40M |
| VREX | Varex Imaging Corporation | $844.60M |
| MYGN | Myriad Genetics Inc. | $824.50M |
| USPH | U.S. Physical Therapy Inc. | $780.99M |
These are five companies in the same sector as INNV with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get InnovAge Holding Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("INNV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | INNV | $10.98 | -0.50% | 0.09M |
| 3 | ||||
| 4 | ||||
| 5 |